Teladoc Health Inc. (NYSE:TDOC) finished Wednesday with an addition of $4.34 to close at $136.02, an upside of 3.30 percent. An average of 2,047,800 shares of common stock have been traded in the last five days. There was a gain of $9.71 in the past week. The last 20 days have seen an average of 2,359,145 shares traded, while the 50-day average volume stands at 2,048,264.
TDOC stock has increased by 1.72% in the last month. The company shares reached their 1-month lowest point of $120.67 on 10/04/21. With the stock rallying to its 52-week high on 02/16/21, shares of the company touched a low of $120.67 and a high of $308.00 in 52 weeks. In spite of this, the price is down -55.84% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
3 days have passed since Teladoc Health Inc. (TDOC) last reported insider trading activity. Trencher Daniel, who is SVP Corporate Strategy, most recently acquired $2,000 shares at $131.06 per share on Oct 11. In this transaction, the insider spent $262,120. Chief Legal Officer, Secretary, Vandervoort Adam C, disposed of 2,000 shares at a price of $133.11 on Sep 15. The insider now owns more than $266,220 worth of shares. Prior to that, SVP Corporate Strategy Trencher Daniel went on to Sale 2,000 shares at $142.96 each on Sep 10. An amount of $285,920 was transacted.
Teladoc Health Inc. (TDOC) has a trailing price-to-earnings (P/E) ratio of 23.70 for the broader industry and 32.30 for the sector. The stock’s beta is 0.27. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 13.22, the price-to-book (PB) ratio at 1.33.
The quick ratio of Teladoc Health Inc. for the three months ended June 29 was 3.80, and the current ratio was 4.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.08 and a total debt to equity ratio of 0.08 for the quarter ending June 29. On the profitability front, the trailing 12-month gross margin is 67.20% against a 5-year average of 69.6%. Teladoc Health Inc.’s EBITDA margin for the year ending June 29 is -30.28%, while its operating margin for the same period stands at -42.10%. Its gross profit as reported stood at $703.13 million compared to revenue of $1.09 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Teladoc Health Inc.’s return on assets was -5.40%, compared to -13.3% over the last five years. In the past year, the return on investment has been -2.50%, and the 5-year average is -12.8%. Meanwhile, the return on equity (ROE) for the past 12 months has been -6.10% and the 5-year average holds at -18.2%. For the broader industry, ROE averaged 9.65 over the past year.
For the three-month period that ended June 29, Teladoc Health Inc. had $2.54 million in cash. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $503.14 million in the quarter, while revenues of $453.68 million were grew 64.07%. The analyst consensus anticipated Teladoc Health Inc.’s latest quarter earnings to come in at -$0.56 per share, but it turned out to be -$0.86, a -53.60% surprise. For the quarter, EBITDA amounted to -$8.12 million. Shareholders own equity worth $159.25 million.
From a technical analysis perspective, let’s take a brief look at Teladoc Health Inc. (TDOC) price momentum. RSI 9-day as of the close on 13 October was 60.30%, suggesting the stock is Neutral, with historical volatility in this time frame at 32.52%.
As of today, TDOC’s price is $131.93 +7.69% or $9.71 from its 5-day moving average. TDOC is currently trading +1.54% higher than its 20-day SMA and -3.20% lower than its 100-day SMA. However, the stock’s current price level is -10.16% below the SMA50 and -31.24% below the SMA200.
The stochastic %K and %D were 61.39% and 54.47%, respectively, and the average true range (ATR) was 4.39. With the 14-day stochastic at 82.00% and the average true range at 4.54, the RSI (14) stands at 53.44%. The stock has reached 3.61 on the 9-day MACD Oscillator while the 14-day reading was at 3.01.
Argus downgraded Teladoc Health Inc. (NYSE: TDOC) to a a Hold rating in its most recent analyst report. Previously, the stock was rated as a a Buy.The consensus rating for Teladoc Health Inc. (TDOC) among analysts is Overweight. According to current brokerage recommendations, 1 brokerage firm advise that investors sell TDOC, while 12 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 15 others rate it as a “buy”.
What is TDOC’s price target for the next 12 months?
Analysts predict a range of price targets between $125.00 and $291.00, with a median target of $182.50. Taking a look at these predictions, the average price target given by analysts for Teladoc Health Inc. (TDOC) stock is $193.08.